Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

A newly developed capture-based sequencing panel for genomic assay of lung cancer.

Genes & genomics - 1 Jul 2020

Im Sun-Wha, Chae Jeesoo, Jang Se Song, Choi Jaeyong, Yun Jihui, Cha Soojin, Kwon Nak-Jung, Jeon Yoon Kyung, Hwang Yoohwa, Kim Miso, Kim Tae Min, Kim Dong-Wan, Kim Jong-Il, Kim Young Tae

Abstract excerpt

BACKGROUND: The increase in genetic alterations targeted by specific chemotherapy in lung cancer has led to the need for universal use of more comprehensive genetic testing, which has highlighted the development of a lung cancer diagnostic panel using next-generation sequencing. OBJECTIVE: We developed a hybridization capture-based massively parallel sequencing assay named Friendly, Integrated, Research-based,...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Data Accuracy
Share to DNA Copy Number Variations

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Genes, Neoplasm

Share to Genomic Structural Variation

Share to INDEL Mutation

Share to Neoplasm Proteins

Share to Precision Medicine

Share to Sensitivity and Specificity

Source

Identifiers

PMID: 32449066
DOI: 10.1007/s13258-020-00949-1

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 3 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

A newly developed capture-based sequencing panel for genomic assay of lung cancer.PMID 32449066Read ↗

Comprehensive Genomic Profiling Facilitates Implementation of the National Comprehensive Cancer Network Guidelines for Lung Cancer Biomarker Testing and Identifies Patients Who May Benefit From Enrollment in Mechanism-Driven Clinical Trials.Semantic proximity Read ↗

Genomic Testing in Lung Cancer: Past, Present, and Future.Semantic proximity Read ↗

Broad, Hybrid Capture-Based Next-Generation Sequencing Identifies Actionable Genomic Alterations in Lung Adenocarcinomas Otherwise Negative for Such Alterations by Other Genomic Testing Approaches.Semantic proximity Read ↗

Application of Comprehensive Genomic Profiling-Based Next-Generation Sequencing Assay to Improve Cancer Care in a Developing Country.Semantic proximity Read ↗

Multiplex gene-panel testing for lung cancer patients.Semantic proximity Read ↗

Germline and somatic mutation profile in Cancer patients revealed by a medium-sized pan-Cancer panel.Semantic proximity Read ↗

Combined Targeted DNA Sequencing in Non-Small Cell Lung Cancer (NSCLC) Using UNCseq and NGScopy, and RNA Sequencing Using UNCqeR for the Detection of Genetic Aberrations in NSCLC.Semantic proximity Read ↗

Molecular profiling and feasibility using a comprehensive hybrid capture panel on a consecutive series of non-small-cell lung cancer patients from a single centreSemantic proximity Read ↗

Lung Cancer GenomicsSemantic proximity Read ↗

Cost-effective shallow genome-wide sequencing for profiling plasma cfDNA signatures to enhance lung cancer detection.Semantic proximity Read ↗

Detection of Multiple Types of Cancer Driver Mutations Using Targeted RNA Sequencing in NSCLCSemantic proximity Read ↗

Validating a targeted next-generation sequencing assay and profiling somatic variants in Chinese non-small cell lung cancer patients.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.